US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Proair

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 59310-579-22 D-1076-2022
Class II · Moderate risk Terminated

Mupirocin Ointment

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0093-1010-42 D-1075-2022
Class II · Moderate risk Terminated

Lidocaine Patch 5%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-3525-30 D-1068-2022
Class II · Moderate risk Terminated

Clonidine Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 00228-2127-10 D-1066-2022
Class II · Moderate risk Terminated

Ketoconazole Cream

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0099-60 D-1065-2022
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-2725-61 D-1059-2022
Class II · Moderate risk Terminated

Sodium Bicarbonate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0536-1047-10 D-1058-2022
Class II · Moderate risk Terminated

Promethazine HCl Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6461-61 D-1057-2022
Class II · Moderate risk Terminated

Metronidazole tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-1453-61 D-1056-2022
Class II · Moderate risk Terminated

Ibuprofen Tablets USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-5853-61 D-1055-2022
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-0430-06 D-1054-2022
Class II · Moderate risk Terminated

Xylocaine + Epinephrine

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-483-27 D-1053-2022
Class II · Moderate risk Terminated

Xylocaine + Epinephrine

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-482-27 D-1052-2022